A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection

American Journal of Pathology

Volumn 179, Issue 4, 2011, Pages 1872-1883

  Renneson, Joelle ^a,b,c,d,e   Guabiraba, Rodrigo ^f   Maillet, Isabelle ^g   Marques, Rafael E ^f   Ivanov, Stoyan ^a,b,c,d,e   Fontaine, Josette ^a,b,c,d,e   Paget, Christophe ^a,b,c,d,e   Quesniaux, Valérie ^g   Faveeuw, Christelle ^a,b,c,e   Ryffel, Bernhard ^g   Teixeira, Mauro M ^f   Trottein, Franois ^a,b,c,d,e,h  

^a INSERM U1019   (France)

^b UNIV LILLE   (France)

^c CNRS   (France)

^d INSERM   (France)

^e Institut Federatif de Recherche 142   (France)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g UNIVERSITÉ D'ORLÉANS   (France)

^h INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA INTERFERON; CD69 ANTIGEN; FAS LIGAND; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CAPILLARY LEAK SYNDROME; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; DENGUE; DENGUE VIRUS; DISEASE MODEL; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; LIVER CELL; LIVER INJURY; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIMARY INFECTION; PRIORITY JOURNAL; SEROTYPE; SPLEEN CELL; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION; TOGAVIRUS INFECTION; UPREGULATION; VIRUS STRAIN; WILD ANIMAL;

ANIMALS; BODY WEIGHT; CYTOKINES; DENGUE; DENGUE VIRUS; FEMALE; GALACTOSYLCERAMIDES; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; NEUTROPHIL ACTIVATION; SURVIVAL ANALYSIS; VIRAL LOAD; VIRUS REPLICATION;

EID: 80053237342     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.06.023     Document Type: Article

References (88)

1. M.G. Guzman, and G. Kouri Dengue: an update Lancet Infect Dis 2 2002 33 42 (Pubitemid 36109304)
2. J.S. Mackenzie, D.J. Gubler, and L.R. Petersen Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses Nat Med 10 2004 S98 S109
3. R.V. Gibbons, and D.W. Vaughn Dengue: an escalating problem BMJ 324 2002 1563 1566 (Pubitemid 34713137)
4. J.L. Deen, E. Harris, B. Wills, A. Balmaseda, S.N. Hammond, C. Rocha, N.M. Dung, N.T. Hung, T.T. Hien, and J.J. Farrar The WHO dengue classification and case definitions: time for a reassessment Lancet 368 2006 170 173 (Pubitemid 43994174)
5. D.J. Gubler Dengue and dengue hemorrhagic fever Clin Microbiol Rev 11 1998 480 496 (Pubitemid 28379096)
6. S. Green, D.W. Vaughn, S. Kalayanarooj, S. Nimmannitya, S. Suntayakorn, A. Nisalak, R. Lew, B.L. Innis, I. Kurane, A.L. Rothman, and F.A. Ennis Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity J Infect Dis 179 1999 755 762 (Pubitemid 29159319)
7. A.L. Rothman, and F.A. Ennis Immunopathogenesis of dengue hemorrhagic fever Virology 257 1999 1 6 (Pubitemid 29391794)
8. A.L. Rothman Dengue: defining protective versus pathologic immunity J Clin Invest 113 2004 946 951 (Pubitemid 38544112)
9. I. Kurane Dengue hemorrhagic fever with special emphasis on immunopathogenesis Comp Immunol Microbiol Infect Dis 30 2007 329 340 (Pubitemid 47450087)
10. B.E. Martina, P. Koraka, and A.D. Osterhaus Dengue virus pathogenesis: an integrated view Clin Microbiol Rev 22 2009 564 581
11. S. Thein, M.M. Aung, T.N. Shwe, M. Aye, A. Zaw, K. Aye, K.M. Aye, and J. Aaskov Risk factors in dengue shock syndrome Am J Trop Med Hyg 56 1997 566 572 (Pubitemid 27230081)
12. A. Balmaseda, S.N. Hammond, L. Perez, Y. Tellez, S.I. Saborio, J.C. Mercado, R. Cuadra, J. Rocha, M.A. Perez, S. Silva, C. Rocha, and E. Harris Serotype-specific differences in clinical manifestations of dengue Am J Trop Med Hyg 74 2006 449 456 (Pubitemid 46774369)
13. J.R. Rodriguez-Madoz, D. Bernal-Rubio, D. Kaminski, K. Boyd, and A. Fernandez-Sesma Dengue virus inhibits the production of type I interferon in primary human dendritic cells J Virol 84 2010 4845 4850
14. Y.C. Chen, and S.Y. Wang Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide J Virol 76 2002 9877 9887
15. A. Couvelard, P. Marianneau, C. Bedel, M.T. Drouet, F. Vachon, D. Henin, and V. Deubel Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis Hum Pathol 30 1999 1106 1110 (Pubitemid 29427169)
16. K. Jessie, M.Y. Fong, S. Devi, S.K. Lam, and K.T. Wong Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization J Infect Dis 189 2004 1411 1418 (Pubitemid 38543590)
17. D.I. Godfrey, and M. Kronenberg Going both ways: immune regulation via CD1d-dependent NKT cells J Clin Invest 114 2004 1379 1388 (Pubitemid 40385565)
18. L. Van Kaer, and S. Joyce Innate immunity: NKT cells in the spotlight Curr Biol 15 2005 R429 R431
19. A. Bendelac, P.B. Savage, and L. Teyton The biology of NKT cells Annu Rev Immunol 25 2007 297 336 (Pubitemid 46697911)
20. N.R. Cohen, S. Garg, and M.B. Brenner Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity Adv Immunol 102 2009 1 94
21. E. Tupin, Y. Kinjo, and M. Kronenberg The unique role of natural killer T cells in the response to microorganisms Nat Rev Microbiol 5 2007 405 417 (Pubitemid 46780078)
22. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides Science 278 1997 1626 1629 (Pubitemid 27516282)
23. V. Cerundolo, J.D. Silk, S.H. Masri, and M. Salio Harnessing invariant NKT cells in vaccination strategies Nat Rev Immunol 9 2009 28 38
24. J. Diana, and A. Lehuen NKT cells: friend or foe during viral infections? Eur J Immunol 39 2009 3283 3291
25. M.S. Tessmer, A. Fatima, C. Paget, F. Trottein, and L. Brossay NKT cell immune responses to viral infection Expert Opin Ther Targets 13 2009 153 162
26. R.R. Kulkarni, S.M. Haeryfar, and S. Sharif The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? J Leukoc Biol 88 2010 635 643
27. B. Grubor-Bauk, A. Simmons, G. Mayrhofer, and P.G. Speck Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR J Immunol 170 2003 1430 1434 (Pubitemid 36139511)
28. A.A. Ashkar, and K.L. Rosenthal Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection J Virol 77 2003 10168 10171 (Pubitemid 37122101)
29. C. De Santo, M. Salio, S.H. Masri, L.Y. Lee, T. Dong, A.O. Speak, S. Porubsky, S. Booth, N. Veerapen, G.S. Besra, H.J. Grone, F.M. Platt, M. Zambon, and V. Cerundolo Invariant NKT cells reduce the immunosuppressive activity of influenza A virusinduced myeloid-derived suppressor cells in mice and humans J Clin Invest 118 2008 4036 4048
30. B. Grubor-Bauk, J.L. Arthur, and G. Mayrhofer Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice J Virol 82 2008 11073 11083
31. J. Diana, T. Griseri, S. Lagaye, L. Beaudoin, E. Autrusseau, A.S. Gautron, C. Tomkiewicz, A. Herbelin, R. Barouki, M. von Herrath, M. Dalod, and A. Lehuen NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner Immunity 30 2009 289 299
32. + T cell response during acute influenza A virus H3N2 pneumonia J Immunol 186 2011 5590 5602
33. E.Y. Kim, J.T. Battaile, A.C. Patel, Y. You, E. Agapov, M.H. Grayson, L.A. Benoit, D.E. Byers, Y. Alevy, J. Tucker, S. Swanson, R. Tidwell, J.W. Tyner, J.D. Morton, M. Castro, D. Polineni, G.A. Patterson, R.A. Schwendener, J.D. Allard, G. Peltz, and M.J. Holtzman Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease Nat Med 14 2008 633 640 (Pubitemid 351809546)
34. H.W. Stout-Delgado, W. Du, A.C. Shirali, C.J. Booth, and D.R. Goldstein Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection Cell Host Microbe 6 2009 446 456
35. M.A. Exley, N.J. Bigley, O. Cheng, A. Shaulov, S.M. Tahir, Q.L. Carter, J. Garcia, C. Wang, K. Patten, H.F. Stills, F.W. Alt, S.B. Snapper, and S.P. Balk Innate immune response to encephalomyocarditis virus infection mediated by CD1d Immunology 110 2003 519 526 (Pubitemid 37521883)
36. S.L. Van Dommelen, H.A. Tabarias, M.J. Smyth, and M.A. Degli-Esposti Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells J Virol 77 2003 1877 1884 (Pubitemid 36110000)
37. J.D. Wesley, M.S. Tessmer, D. Chaukos, and L. Brossay NK cell-like behavior of Valpha14i NK T cells during MCMV infection PLoS Pathog 4 2008 e1000106
38. T.R. Johnson, S. Hong, L. Van Kaer, Y. Koezuka, and B.S. Graham NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus J Virol 76 2002 4294 4303 (Pubitemid 34309565)
39. I. Tsunoda, T. Tanaka, and R.S. Fujinami Regulatory role of CD1d in neurotropic virus infection J Virol 82 2008 10279 10289
40. O. Levy, J.S. Orange, P. Hibberd, S. Steinberg, P. LaRussa, A. Weinberg, S.B. Wilson, A. Shaulov, G. Fleisher, R.S. Geha, F.A. Bonilla, and M. Exley Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells J Infect Dis 188 2003 948 953 (Pubitemid 37268242)
41. K.E. Nichols, J. Hom, S.Y. Gong, A. Ganguly, C.S. Ma, J.L. Cannons, S.G. Tangye, P.L. Schwartzberg, G.A. Koretzky, and P.L. Stein Regulation of NKT cell development by SAP, the protein defective in XLP Nat Med 11 2005 340 345 (Pubitemid 40460564)
42. S. Rigaud, M.C. Fondaneche, N. Lambert, B. Pasquier, V. Mateo, P. Soulas, L. Galicier, F. Le Deist, F. Rieux-Laucat, P. Revy, A. Fischer, B.G. de Saint, and S. Latour XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome Nature 444 2006 110 114 (Pubitemid 44684766)
43. M. Locci, E. Draghici, F. Marangoni, M. Bosticardo, M. Catucci, A. Aiuti, C. Cancrini, L. Marodi, T. Espanol, R.G. Bredius, A.J. Thrasher, A. Schulz, J. Litzman, M.G. Roncarolo, G. Casorati, P. Dellabona, and A. Villa The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function J Exp Med 206 2009 735 742
44. A. Atrasheuskaya, P. Petzelbauer, T.M. Fredeking, and G. Ignatyev Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection FEMS Immunol Med Microbiol 35 2003 33 42 (Pubitemid 36173502)
45. D.G. Souza, C.T. Fagundes, L.P. Sousa, F.A. Amaral, R.S. Souza, A.L. Souza, E.G. Kroon, D. Sachs, F.Q. Cunha, E. Bukin, A. Atrasheuskaya, G. Ignatyev, and M.M. Teixeira Essential role of platelet-activating factor receptor in the pathogenesis of dengue virus infection Proc Natl Acad Sci USA 106 2009 14138 14143
46. I. Assuncao-Miranda, F.A. Amaral, F.A. Bozza, C.T. Fagundes, L.P. Sousa, D.G. Souza, P. Pacheco, G. Barbosa-Lima, R.N. Gomes, P.T. Bozza, A.T. Da Poian, M.M. Teixeira, and M.T. Bozza Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection FASEB J 24 2010 218 228
47. R. Guabiraba, R.E. Marques, A.G. Besnard, C.T. Fagundes, D.G. Souza, B. Ryffel, and M.M. Teixeira Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice PLoS One 5 2010 e15680
48. S. Shresta, J.L. Kyle, H.M. Snider, M. Basavapatna, P.R. Beatty, and E. Harris Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical J Virol 78 2004 2701 2710 (Pubitemid 38314329)
49. V.V. Parekh, M.T. Wilson, and L. Van Kaer iNKT-cell responses to glycolipids Crit Rev Immunol 25 2005 183 213 (Pubitemid 41444904)
50. A. Chiba, C.C. Dascher, G.S. Besra, and M.B. Brenner Rapid NKT cell responses are self-terminating during the course of microbial infection J Immunol 181 2008 2292 2302
51. S. Kim, S. Lalani, V.V. Parekh, T.L. Vincent, L. Wu, and L. Van Kaer Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice J Clin Invest 118 2008 2301 2315 (Pubitemid 351872347)
52. J.A. Hobbs, S. Cho, T.J. Roberts, V. Sriram, J. Zhang, M. Xu, and R.R. Brutkiewicz Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus J Virol 75 2001 10746 10754 (Pubitemid 33031544)
53. Y. Lin, T.J. Roberts, C.R. Wang, S. Cho, and R.R. Brutkiewicz Long-term loss of canonical NKT cells following an acute virus infection Eur J Immunol 35 2005 879 889 (Pubitemid 40425544)
54. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura Critical contribution of liver natural killer T cells to a murine model of hepatitis Proc Natl Acad Sci USA 97 2000 5498 5503 (Pubitemid 30313747)
55. G. Wingender, P. Krebs, B. Beutler, and M. Kronenberg Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency J Immunol 185 2010 2721 2729
56. S. Kalayanarooj, D.W. Vaughn, S. Nimmannitya, S. Green, S. Suntayakorn, N. Kunentrasai, W. Viramitrachai, S. Ratanachu-eke, S. Kiatpolpoj, B.L. Innis, A.L. Rothman, A. Nisalak, and F.A. Ennis Early clinical and laboratory indicators of acute dengue illness J Infect Dis 176 1997 313 321 (Pubitemid 27328752)
57. M. Juffrie, G.M. Der Meer, C.E. Hack, K. Haasnoot, Sutaryo, A.J. Veerman, and L.G. Thijs Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation Infect Immun 68 2000 702 707 (Pubitemid 30056526)
58. T.N. Chau, N.T. Quyen, T.T. Thuy, N.M. Tuan, D.M. Hoang, N.T. Dung, l.B. Lien, N.T. Quy, N.T. Hieu, L.T. Hieu, T.T. Hien, N.T. Hung, J. Farrar, and C.P. Simmons Dengue in Vietnamese infants: results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity J Infect Dis 198 2008 516 524
59. C.C. Liu, K.J. Huang, Y.S. Lin, T.M. Yeh, H.S. Liu, and H.Y. Lei Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection J Med Virol 68 2002 241 252
60. K. Kakimi, L.G. Guidotti, Y. Koezuka, and F.V. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J Exp Med 192 2000 921 930
61. M.A. Exley, N.J. Bigley, O. Cheng, S.M. Tahir, S.T. Smiley, Q.L. Carter, H.F. Stills, M.J. Grusby, Y. Koezuka, M. Taniguchi, and S.P. Balk CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus J Leukoc Biol 69 2001 713 718 (Pubitemid 32466408)
62. L.P. Ho, L. Denney, K. Luhn, D. Teoh, C. Clelland, and A.J. McMichael Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection Eur J Immunol 38 2008 1913 1922
63. M. Lucas, S. Gadola, U. Meier, N.T. Young, G. Harcourt, A. Karadimitris, N. Coumi, D. Brown, G. Dusheiko, V. Cerundolo, and P. Klenerman Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection J Virol 77 2003 2251 2257 (Pubitemid 36110039)
64. E. Durante-Mangoni, R. Wang, A. Shaulov, Q. He, I. Nasser, N. Afdhal, M.J. Koziel, and M.A. Exley Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells J Immunol 173 2004 2159 2166 (Pubitemid 38971655)
65. H.J. van der Vliet, J.W. Molling, B.M. von Blomberg, W. Kolgen, A.G. Stam, T.D. de Gruijl, C.J. Mulder, H.L. Janssen, N. Nishi, A.J. van den Eertwegh, R.J. Scheper, and C.J. van Nieuwkerk Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients Clin Immunol 114 2005 183 189 (Pubitemid 40082384)
66. M. Inoue, T. Kanto, H. Miyatake, I. Itose, M. Miyazaki, T. Yakushijin, M. Sakakibara, N. Kuzushita, N. Hiramatsu, T. Takehara, A. Kasahara, and N. Hayashi Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection J Hepatol 45 2006 190 196
67. V.D. Gonzalez, K. Falconer, J. Michaelsson, M. Moll, O. Reichard, A. Alaeus, and J.K. Sandberg Expansion of CD56-NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin Clin Immunol 128 2008 46 56
68. S. Toyabe, S. Seki, T. Iiai, K. Takeda, K. Shirai, H. Watanabe, H. Hiraide, M. Uchiyama, and T. Abo Requirement of IL-4 and liver NK1+ T cells for concanavalin Ainduced hepatic injury in mice J Immunol 159 1997 1537 1542 (Pubitemid 127484135)
69. Y. Osman, T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, K. Okumura, and T. Abo Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide Eur J Immunol 30 2000 1919 1928 (Pubitemid 30456188)
70. M. Biburger, and G. Tiegs Alpha-galactosylceramideinduced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells J Immunol 175 2005 1540 1550 (Pubitemid 41023055)
71. C.M. Lappas, Y.J. Day, M.A. Marshall, V.H. Engelhard, and J. Linden Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation J Exp Med 203 2006 2639 2648 (Pubitemid 44833340)
72. P. Arrenberg, I. Maricic, and V. Kumar Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice Gastroenterology 140 2011 646 655
73. N.A. Nagarajan, and M. Kronenberg Invariant NKT cells amplify the innate immune response to lipopolysaccharide J Immunol 178 2007 2706 2713 (Pubitemid 46335652)
74. C.K. Hu, F. Venet, D.S. Heffernan, Y.L. Wang, B. Horner, X. Huang, C.S. Chung, S.H. Gregory, and A. Ayala The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock J Immunol 182 2009 2467 2475
75. M.S. Duthie, M. Kahn, M. White, R.P. Kapur, and S.J. Kahn Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection Infect Immun 73 2005 181 192 (Pubitemid 40041108)
76. E. Ambrosino, M. Terabe, R.C. Halder, J. Peng, S. Takaku, S. Miyake, T. Yamamura, V. Kumar, and J.A. Berzofsky Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis J Immunol 179 2007 5126 5136
77. R.C. Halder, C. Aguilera, I. Maricic, and V. Kumar Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease J Clin Invest 117 2007 2302 2312 (Pubitemid 47219575)
78. T. Mallevaey, J. Fontaine, L. Breuilh, C. Paget, A. Castro-Keller, C. Vendeville, M. Capron, M. Leite-de-Moraes, F. Trottein, and C. Faveeuw Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis Infect Immun 75 2007 2171 2180 (Pubitemid 46744303)
79. P. Arrenberg, R. Halder, and V. Kumar Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens J Cell Physiol 218 2009 246 250
80. H. Liao, J. Xu, and J. Huang FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells J Med Virol 82 2010 1392 1399
81. A.L. Cornish, R. Keating, K. Kyparissoudis, M.J. Smyth, F.R. Carbone, and D.I. Godfrey NKT cells are not critical for HSV-1 disease resolution Immunol Cell Biol 84 2006 13 19
82. Y.W. Lin, K.J. Wang, H.Y. Lei, Y.S. Lin, T.M. Yeh, H.S. Liu, C.C. Liu, and S.H. Chen Virus replication and cytokine production in dengue virusinfected human B lymphocytes J Virol 76 2002 12242 12249
83. M.M. Mangada, and A.L. Rothman Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes J Immunol 175 2005 2676 2683 (Pubitemid 41113883)
84. E. Kamau, R. Takhampunya, T. Li, E. Kelly, K.K. Peachman, J.A. Lynch, P. Sun, and D.R. Palmer Dengue virus infection promotes translocation of high mobility group box 1 protein from the nucleus to the cytosol in dendritic cells, upregulates cytokine production and modulates virus replication J Gen Virol 90 2009 1827 1835
85. S. Shresta, K.L. Sharar, D.M. Prigozhin, H.M. Snider, P.R. Beatty, and E. Harris Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice J Immunol 175 2005 3946 3954 (Pubitemid 41292056)
86. I. Kurane, D. Hebblewaite, W.E. Brandt, and F.A. Ennis Lysis of dengue virusinfected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity J Virol 52 1984 223 230 (Pubitemid 14000490)
87. S. Green, S. Pichyangkul, D.W. Vaughn, S. Kalayanarooj, S. Nimmannitya, A. Nisalak, I. Kurane, A.L. Rothman, and F.A. Ennis Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever J Infect Dis 180 1999 1429 1435 (Pubitemid 29506442)
88. E.L. Azeredo, L.M. Oliveira-Pinto, S.M. Zagne, D.I. Cerqueira, R.M. Nogueira, and C.F. Kubelka NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease Clin Exp Immunol 143 2006 345 356